In clinical studies, CM showed anti-inflammatory effects by inhibiting serum levels of pro-inflammatory markers including single-cell chemotactic protein, hyaluronic acid, MCP-1, TGF-β1 and chemokines in patients with hepatitis C virus and autism. The gene discussed is CCL2; the disease is autism.